Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Preveceutical Med Inc New (PRVCF)

Preveceutical Med Inc New (PRVCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,624
  • Shares Outstanding, K 586,812
  • Annual Sales, $ 0 K
  • Annual Income, $ -860 K
  • EBIT $ -2 M
  • EBITDA $ -2 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.00 on 12/01/25
  • Next Earnings Date 04/29/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0110 +52.73%
on 01/20/26
0.0187 -10.16%
on 01/15/26
-0.0011 (-6.15%)
since 01/09/26
3-Month
0.0037 +354.05%
on 12/08/25
0.0279 -39.78%
on 12/19/25
-0.0034 (-16.83%)
since 11/10/25
52-Week
0.0037 +354.05%
on 12/08/25
0.0436 -61.47%
on 10/30/25
-0.0023 (-12.04%)
since 02/10/25

Most Recent Stories

More News
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents

Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce it has...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Expands Financing and Approves Key Resolutions at Annual Meeting

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. PreveCeutical...

PRVCF : 0.0168 (+2.44%)
PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics

Vancouver, British Columbia--(Newsfile Corp. - September 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer

Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting

Vancouver, British Columbia--(Newsfile Corp. - July 9, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its News...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Announces Date for Annual General and Special Meeting

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)
PreveCeutical Welcomes Stephen Glover as Corporate Advisor

Vancouver, British Columbia--(Newsfile Corp. - May 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops...

PREV.CN : 0.0200 (unch)
PRVCF : 0.0168 (+2.44%)

Business Summary

PreveCeutical Medical Inc. is a health sciences company which develops preventive therapies utilizing organic and nature identical products. The company's research and development programs includes dual gene therapy for curative and prevention therapies for diabetes and obesity; a Sol-gel platform for...

See More

Key Turning Points

3rd Resistance Point 0.0168
2nd Resistance Point 0.0168
1st Resistance Point 0.0168
Last Price 0.0168
1st Support Level 0.0168
2nd Support Level 0.0168
3rd Support Level 0.0168

See More

52-Week High 0.0436
Fibonacci 61.8% 0.0284
Fibonacci 50% 0.0236
Fibonacci 38.2% 0.0189
Last Price 0.0168
52-Week Low 0.0037

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar